Page last updated: 2024-12-08

3,4-epithiobutanenitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3,4-epithiobutanenitrile: thiirane occuring naturally in cruciferous vegetables; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID148821
CHEBI ID183064
MeSH IDM0120925

Synonyms (15)

Synonym
2-(thiiran-2-yl)acetonitrile
CHEBI:183064
1-cyano-2,3-epithiopropane
thiiraneacetonitrile
3,4-epithiobutanenitrile
thiiraneacetonitrile, (+-)-
(+-)-thiiraneacetonitrile
58130-93-1
76786-80-6
thiirane-2-acetonitrile
BKIZJNMVTRYGSW-UHFFFAOYSA-N
(cyanomethyl)thiirane
thiiraneacetonitrile, 9ci
(thiiran-2-yl)acetonitrile
DTXSID20973702
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
thiirane
epithionitrile
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]